NCT01995188 2017-10-04A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerGenentech, Inc.Phase 1 Completed41 enrolled
NCT01991210 2017-08-21A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)Genentech, Inc.Phase 2 Terminated95 enrolled